These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12360496)

  • 1. Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy.
    Yao N; Hong Z; Lau JY
    Gastroenterology; 2002 Oct; 123(4):1350-63. PubMed ID: 12360496
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

  • 3. Virology of hepatitis B and C viruses and antiviral targets.
    Pawlotsky JM
    J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of viral hepatitis.
    Pawlotsky JM
    Gastroenterology; 2002 May; 122(6):1554-68. PubMed ID: 12016423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis B and C virus mutants. Clinical and therapeutical implications].
    Andreu J; Lissen E
    Gastroenterol Hepatol; 1995 Apr; 18(4):180-5. PubMed ID: 16541565
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing a low-cost drug resistance database for viral hepatitis.
    Kuiken C
    Antivir Ther; 2010; 15(3 Pt B):517-20. PubMed ID: 20516573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
    Berenguer M; Wright TL
    Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
    Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
    Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
    Shakya N; Vedi S; Liang C; Agrawal B; Tyrrell DL; Kumar R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6475-80. PubMed ID: 22985854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.
    Mascolini M; Mellors JW; Richman DD; Boucher CA; Larder BA
    Antivir Ther; 2011; 16(2):263-86. PubMed ID: 21447877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18th International Conference on Antiviral Research. Antivirals.
    Kibble A
    IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection.
    Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
    J Hepatol; 2017 Nov; 67(5):1106-1108. PubMed ID: 28438688
    [No Abstract]   [Full Text] [Related]  

  • 17. American Association for the Study of Liver Diseases (AASLD)--56th Annual Meeting.
    Phend C
    IDrugs; 2006 Feb; 9(2):96-100. PubMed ID: 16523396
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient.
    Mima A; Iehara N; Matsubara T; Yamamoto S; Abe H; Nagai K; Matsuura M; Murakami T; Kishi S; Araoka T; Kishi F; Kondo N; Shigeta R; Yoshikawa K; Takahashi T; Kita T; Doi T; Fukatsu A
    Clin Nephrol; 2010 Feb; 73(2):167-9. PubMed ID: 20129026
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C Viruses and Biologics.
    Grewal P; Sanghera R
    Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.